[1] |
World Health Organization. Global tuberculosis report 2019[R]. Geneva, Switzerland:World Health Organization, 2019.
|
[2] |
LIU C H, LIU H Y, GE B X. Innate immunity in tuberculosis:host defense vs pathogen evasion[J]. Cell Mol Immunol, 2017, 14(12):963-975.
|
[3] |
BEHR M A, WILSON M A, GILL W P, et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray[J]. Science, 1999, 284(5419):1520-1523.
|
[4] |
BERTHET F X, RASMUSSEN P B, ROSENKRANDS I, et al. A Mycobacterium tuberculosis operon encoding ESAT=6 and a novel low-molecular-mass culture filtrate protein (CFP-10)[J]. Microbiology, 1998, 144(11):3195-3203.
|
[5] |
LI L, YANG B Y, YU S F, et al. Human CD8+ T cells from TB pleurisy respond to four immunodominant epitopes in Mtb CFP10 restricted by HLA-B alleles[J]. PLoS One, 2013, 8(12):e82196.
|
[6] |
HU S, YU W L, HU C Y, et al. Conjugation of the CRM197-inulin conjugate significantly increases the immunogenicity of Mycobacterium tuberculosis CFP10-TB10. 4 fusion protein[J]. Bioorg Med Chem, 2017, 25(21):5968-5974.
|
[7] |
NAMVARPOUR M, TEBIANIAN M, MANSOURI R, et al. Comparison of different immunization routes on the immune responses induced by Mycobacterium tuberculosis ESAT-6/CFP-10 recombinant protein[J]. Biologicals, 2019, 59:6-11.
|
[8] |
WANG C H, LU J B, DU W X, et al. Ag85b/ESAT6-CFP10 adjuvanted with aluminum/poly-IC effectively protects guinea pigs from latent Mycobacterium tuberculosis infection[J]. Vaccine, 2019, 37(32):4477-4484.
|
[9] |
WARDS B J, DE LISLE G W, COLLINS D M. An esat6 knockout mutant of Mycobacterium bovis produced by homologous recombination will contribute to the development of a live tuberculosis vaccine[J]. Tuber Lung Dis, 2000, 80(4-5):185-189.
|
[10] |
GANGULY N, GIANG P H, GUPTA C, et al. Mycobacterium tuberculosis secretory proteins CFP-10, ESAT-6 and the CFP10:ESAT6 complex inhibit lipopolysaccharide-induced NF-κB transactivation by downregulation of reactive oxidative species (ROS) production[J]. Immunol Cell Biol, 2008, 86(1):98-106.
|
[11] |
ALVAREZ-JIMÉNEZ V D, LEYVA-PAREDES K, GARCÍA-MARTÍNEZ M, et al. Extracellular vesicles released from Mycobacterium tuberculosis-infected neutrophils promote macrophage autophagy and decrease intracellular mycobacterial survival[J]. Front Immunol, 2018, 9:272.
|
[12] |
KUMAR M, MAJUMDER D, MAL S, et al. Activating transcription factor 3 modulates the macrophage immune response to Mycobacterium tuberculosis infection via reciprocal regulation of inflammatory genes and lipid body formation[J]. Cell Microbiol, 2020, 22(3):e13142.
|
[13] |
PI J, SHEN L, YANG E Z, et al. Macrophage-targeted Isoniazid-selenium nanoparticles promote antimicrobial immunity and synergize bactericidal destruction of tuberculosis bacilli[J]. Angew Chem Int Ed, 2020, 59(8):3226-3234.
|
[14] |
ROCA F J, WHITWORTH L J, REDMOND S, et al. TNF induces pathogenic programmed macrophage necrosis in tuberculosis through a mitochondrial-lysosomal-endoplasmic reticulum circuit[J]. Cell, 2019, 178(6):1344-1361.e11.
|
[15] |
SCORDO J M, KNOELL D L, TORRELLES J B. Alveolar epithelial cells in Mycobacterium tuberculosis infection:active players or innocent bystanders?[J]. J Innate Immun, 2016, 8(1):3-14.
|
[16] |
RYNDAK M B, LAAL S. Mycobacterium tuberculosis primary infection and dissemination:a critical role for alveolar epithelial cells[J]. Front Cell Infect Microbiol, 2019, 9:299.
|
[17] |
YANG Y, SUN Y F, XU J R, et al. Epithelial cells attenuate toll-like receptor-mediated inflammatory responses in monocyte-derived macrophage-like cells to Mycobacterium tuberculosis by modulating the PI3K/Akt/mTOR signaling pathway[J]. Mediators Inflamm, 2018, 2018:3685948.
|
[18] |
RYU J H, KIM C H, YOON J H. Innate immune responses of the airway epithelium[J]. Mol Cells, 2010, 30(3):173-183.
|
[19] |
FITZGERALD K A, KAGAN J C. Toll-like receptors and the control of immunity[J]. Cell, 2020, 180(6):1044-1066.
|
[20] |
MAAS M, MICHEL A L, RUTTEN V P M G. Facts and dilemmas in diagnosis of tuberculosis in wildlife[J]. Comp Immunol Microbiol Infect Dis, 2013, 36(3):269-285.
|
[21] |
DEBBABI H, GHOSH S, KAMATH A B, et al. Primary type Ⅱ alveolar epithelial cells present microbial antigens to antigen-specific CD4+ T cells[J]. Am J Physiol Lung Cell Mol Physiol, 2005, 289(2):L274-L279.
|
[22] |
RENSHAW P S, PANAGIOTIDOU P, WHELAN A, et al. Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10, and the ESAT-6*CFP-10 complex. Implications for pathogenesis and virulence[J]. J Biol Chem, 2002, 277(24):21598-21603.
|
[23] |
CHEN Y Y, LIN C W, HUANG W F, et al. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis[J]. J Microbiol Immunol Infect, 2017, 50(1):90-96.
|
[24] |
XIE X L, HAN M, ZHANG L, et al. Effects of Mycobacterium tuberculosis ESAT6-CFP10 protein on cell viability and production of nitric oxide in alveolar macrophages[J]. Jundishapur J Microbiol, 2016, 9(6):e33264.
|
[25] |
BAGHANI A A, SOLEIMANPOUR S, FARSIANI H, et al. CFP10:mFcγ2 as a novel tuberculosis vaccine candidate increases immune response in mouse[J]. Iran J Basic Med Sci, 2017, 20(2):122-130.
|
[26] |
AGUILO N, GONZALO-ASENSIO J, ALVAREZ-ARGUEDAS S, et al. Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis[J]. Nat Commun, 2017, 8(1):16085.
|
[27] |
WELIN A, BJÖRNSDOTTIR H, WINTHER M, et al. CFP-10 from Mycobacterium tuberculosis selectively activates human neutrophils through a pertussis toxin-sensitive chemotactic receptor[J]. Infect Immun, 2015, 83(1):205-213.
|
[28] |
GAO L Y, GUO S, MCLAUGHLIN B, et al. A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT-6 secretion[J]. Mol Microbiol, 2004, 53(6):1677-1693.
|
[29] |
TRAJKOVIC V, SINGH G, SINGH B, et al. Effect of Mycobacterium tuberculosis-specific 10-kilodalton antigen on macrophage release of tumor necrosis factor alpha and nitric oxide[J]. Infect Immun, 2002, 70(12):6558-6566.
|
[30] |
SINGH B, SINGH G, TRAJKOVIC V, et al. Intracellular expression of Mycobacterium tuberculosis-specific 10-kDa antigen down-regulates macrophage B7. 1 expression and nitric oxide release[J]. Clin Exp Immunol, 2003, 134(1):70-77.
|
[31] |
KHAN A, BAKHRU P, SAIKOLAPPAN S, et al. An autophagy-inducing and TLR-2 activating BCG vaccine induces a robust protection against tuberculosis in mice[J]. NPJ Vaccines, 2019, 4:34.
|
[32] |
SEGHATOLESLAM A, HEMMATI M, EBADAT S, et al. Macrophage immune response suppression by recombinant Mycobacterium tuberculosis antigens, the ESAT-6, CFP-10, and ESAT-6/CFP-10 fusion proteins[J]. Iran J Med Sci, 2016, 41(4):296-304.
|
[33] |
ZUO X S, WANG L, BAO Y Q, et al. The ESX-1 virulence factors downregulate miR-147-3p in Mycobacterium marinum-infected macrophages[J]. Infect Immun, 2020, 88(6):e00088-20.
|